Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia. - Cosgun KN; Jumaa H; Robinson ME; Cheng Z; Oulghazi S; Kume K; Fonseca Arce D; Agadzhanian N; Kistner KM; Leveille E; Drivet E; Yu F; et al. (Nature cancer, 2026)